Business
Novavax chief ‘not able to predict’ Australian approval date for vaccine – Sydney Morning Herald
The company behind the third major COVID vaccine that Australia has ordered has been delayed in filing for global approvals.
The chief executive of coronavirus vaccine maker Novavax has admitted the company will have to delay filing for approvals of the product until July and will not put a date on when the vaccine is likely to receive the green light in Australia.
The Australian government has ordered 51 million doses of the Novavax vaccine, which had been expected to start being delivered as early as September this year.
Novavax said the trial, which enrolled 15,000 people aged 18 to 84, was expected to be used to apply…
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business22 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General23 hours agoRush to buy homes before rate cuts send prices soaring
-
Business20 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025